Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 4/20 | 0.32 |
| ▸ | JAK1 | P23458 | 3/20 | 0.31 |
| ▸ | TYK2 | P29597 | 1/20 | 0.31 |
| ▸ | JAK3 | P52333 | 1/20 | 0.31 |
| ▸ | GCG | P01275 | 1/20 | 0.31 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29567261 | 1.00 | JAK2 (0.32) | JAK2JAK1TYK2JAK3GCG | |
| SCHEMBL29568051 | 0.93 | JAK2 (0.33) | JAK2JAK1TYK2JAK3GCG | |
| SCHEMBL29480694 | 0.93 | JAK2 (0.33) | JAK2JAK1TYK2JAK3GCG | |
| SCHEMBL22735791 | 0.93 | JAK2 (0.33) | JAK2JAK1TYK2JAK3GCG | |
| SCHEMBL22736486 | 0.93 | JAK2 (0.33) | JAK2JAK1TYK2JAK3GCG | |
| SCHEMBL29568285 | 0.93 | JAK2 (0.33) | JAK2JAK1TYK2JAK3GCG | |
| SCHEMBL22736539 | 0.91 | JAK2 (0.31) | JAK2JAK1TYK2JAK3GCG | |
| SCHEMBL29480732 | 0.91 | JAK2 (0.31) | JAK2JAK1TYK2JAK3GCG | |
| SCHEMBL29567880 | 0.91 | JAK2 (0.32) | JAK2JAK1TYK2JAK3GRM4 | |
| SCHEMBL22716739 | 0.88 | JAK2 (0.33) | JAK2JAK1TYK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020240586-A1 | NOVEL COMPOUNDS FOR INHIBITION OF JANUS KINASE 1 | MANKIND PHARMA LTD. (IN) | 2020-12-03 | — | — | WO | disclosed |